52 results
8-K
EX-99.2
BPTH
Bio-Path Holdings Inc
9 Nov 22
Entry into a Material Definitive Agreement
8:30am
of Sale Disclosure Package” means the Base Prospectus, any preliminary prospectus supplement, any subscription agreement between the Company … hereto shall hereafter expressly agree in writing to treat as part of the Time of Sale Disclosure Package. The term “any Prospectus” shall mean
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
17 Feb 21
Placement Agency Agreement
5:11pm
Prospectus, as the case may be. As used in this paragraph and elsewhere in this Agreement, “Time of Sale Disclosure Package” means the Base Prospectus … to treat as part of the Time of Sale Disclosure Package. The term “any Prospectus” shall mean, as the context requires, the Base Prospectus, the Final
8-K
EX-99.1
BPTH
Bio-Path Holdings Inc
2 Apr 24
Bio-Path Holdings Provides 2024 Clinical and Operational Update
4:10pm
package to accompany prexigebersen treatment and expects to evaluate prexigebersen for the treatment of obesity. In addition, one further drug candidate … in an Investigational New Drug (IND) application.
Development of Molecular Biomarkers – Bio-Path is developing a molecular biomarker package to accompany
8-K
EX-10.1
8xhye
7 Aug 23
Bio-Path Holdings, Inc. Announces Pricing of $2.1 Million Public Offering
4:42pm
8-K
EX-99.1
6xjymo uvxc7
22 Dec 14
Bio-Path Holdings to Initiate Development of Liposomal Bcl-2 in Follicular Lymphoma
12:00am
8-K
EX-99.1
nj8gpff9jc
5 Apr 21
Regulation FD Disclosure
4:54pm
424B3
42h19
7 Aug 23
Prospectus supplement
7:21am